SAN ANTONIO, Texas– Intrinsic Imaging LLC, a bio/pharmaceutical medical imaging services organization, and Merge Healthcare, a health IT solutions company, announced today that they have entered into a technology agreement; Intrinsic will become the first company to implement Merge’s new Clinical Imaging Management System (CIMS).
Merge CIMS is the first commercially available solution for managing all aspects of imaging in clinical trials. Through defining investigator sites, enabling rapid electronic image acquisition from these sites over the Internet, providing detailed image tracking and enabling the rapid radiologic analysis, adjudication and reporting of images, CIMS enables the transparent execution of imaging trials complete with seamless EDC integration.
Intrinsic’s team of more than 60 board-certified diagnostic radiologists will utilize Merge CIMS for complete clinical trial image management. Intrinsic’s experienced clinical team provides pharmaceutical and biotech sponsors with comprehensive imaging core lab services across all therapeutic areas including oncology, neurology, cardiology, rheumatology and endocrinology.
